This course covers the goals and outcomes of CAR T cell therapy for lymphoma, focusing on improving safety and efficacy through the latest research. The individual skills taught include understanding CAR T targets, antigen escape, stem cells, and safety measures. The teaching method involves a discussion led by a UCLA hematologist. The intended audience includes individuals interested in the advancements of engineered cell therapy for cancer treatment.
CAR T at UCLA - Driving the Progress of Engineered Cell Therapy
University of California, Los Angeles via YouTube
Overview
Syllabus
Introduction
Research Goals
CAR T Targets
Antigen Escape
Stem Cells
Safety
Conclusion
Leukemia Lymphoma Society
Climb to Cure
Questions
Taught by
UCLA Health
